2 results
Approved WMOWill not start
The objective of this study is to obtain the absolute bioavailability of voriconazole in critically ill ICU patients.
Approved WMOCompleted
PRINCIPAL OBJECTIVE To evaluate whether sequential therapy with tacrolimus for 9 months (6 months of full therapy and 3 months of tapering doses) followed by a dose of RTX leads to a greater increase in the proportion of primary MN patients with…